Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index; 1 of the 5 sources its claims cite were checked for support.

High-Density SNP Screening of the Major Histocompatibility Complex in Systemic Lupus Erythematosus Demonstrates Strong Evidence for Independent Susceptibility Regions

Open access

Abstract

A substantial genetic contribution to systemic lupus erythematosus (SLE) risk is conferred by major histocompatibility complex (MHC) gene(s) on chromosome 6p21. Previous studies in SLE have lacked statistical power and genetic resolution to fully define MHC influences. We characterized 1,610 Caucasian SLE cases and 1,470 parents for 1,974 MHC SNPs, the highly polymorphic HLA-DRB1 locus, and a panel of ancestry informative markers. Single-marker analyses revealed strong signals for SNPs within several MHC regions, as well as with HLA-DRB1 (global p = 9.99 x 10(-16)). The most strongly associated DRB1 alleles were: *0301 (odds ratio, OR = 2.21, p = 2.53 x 10(-12)), *1401 (OR = 0.50, p = 0.0002), and *1501 (OR = 1.39, p = 0.0032). The MHC region SNP demonstrating the strongest evidence of association with SLE was rs3117103, with OR = 2.44 and p = 2.80 x 10(-13). Conditional haplotype and stepwise logistic regression analyses identified strong evidence for association between SLE and the extended class I, class I, class III, class II, and the extended class II MHC regions. Sequential removal of SLE-associated DRB1 haplotypes revealed independent effects due to variation within OR2H2 (extended class I, rs362521, p = 0.006), CREBL1 (class III, rs8283, p = 0.01), and DQB2 (class II, rs7769979, p = 0.003, and rs10947345, p = 0.0004). Further, conditional haplotype analyses demonstrated that variation within MICB (class I, rs3828903, p = 0.006) also contributes to SLE risk independent of HLA-DRB1*0301. Our results for the first time delineate with high resolution several MHC regions with independent contributions to SLE risk. We provide a list of candidate variants based on biologic and functional considerations that may be causally related to SLE risk and warrant further investigation.

Overview

CoChat Summary

## TL;DR

This study used high-density MHC SNP screening plus HLA-DRB1 genotyping in European-ancestry SLE cases/families to show that multiple, independent susceptibility regions contribute to SLE risk. The strongest signals were at HLA-DRB1, with the top SNP rs3117103 also showing strong association, and follow-up conditional analyses supported additional effects in OR2H2, CREBL1, MICB, and DQB2.

## Key findings

  • In 1,610 Caucasian SLE cases and 1,470 parents, the strongest HLA-DRB1 associations were for DRB1*0301 (OR = 2.21, p = 2.53×10−12), DRB1*1401 (OR = 0.50, p = 0.0002), and DRB1*1501 (OR = 1.39, p = 0.0032).
  • Among 1,974 MHC SNPs passing quality control, the strongest SNP association was rs3117103 (OR = 2.44, p = 2.80×10−13); the paper also reports rs3117103 remained strong in a more homogeneous Northern European subset (OR = 2.49, p = 1.62×10−13).
  • Conditional haplotype and stepwise logistic regression analyses identified independent signals in multiple regions: OR2H2 (rs362521, p = 0.006), CREBL1 (rs8283, p = 0.01), DQB2 (rs7769979, p = 0.003; rs10947345, p = 0.0004), and MICB (rs3828903, p = 0.006).
  • The strongest associated extended haplotype contained DRB1*0301 (15% transmitted vs. 6% non-transmitted; OR = 2.63, p = 8.32×10−15); a second associated haplotype contained DRB1*1501 (9% transmitted vs. 6% non-transmitted; OR = 1.54, p = 0.0025).

## Methods

  • Family-based and case-based genetic association study of 1,610 Caucasian SLE cases and 1,470 parents from trio families; cases came from three independent collections, and all SLE cases met American College of Rheumatology criteria.
  • Genotyping included HLA-DRB1, 2,360 MHC SNPs on Illumina’s Combined MHC panel, and 384 ancestry informative markers; after quality control, 2,873 samples and 1,974 MHC SNPs remained for analysis.
  • Main analyses used RPE, univariate association tests, TDT, conditional haplotype methods, stepwise logistic regression, haplotype analysis, LD analysis, and BEAGLE/PHASE/UNPHASED/WHAP/PLINK/STATA/SAS as described in the paper.

## Limitations

  • The paper states that MHC coverage was not comprehensive: the marker set was not designed to directly assess rare variants or multi-allelic markers such as indels or copy-number variants, and it did not characterize other classical HLA genes besides HLA-DRB1.
  • The authors note they cannot determine which associated variants are causal versus proxies in LD, so the reported associations are not proof of causation.
  • Evident from the text: the study analyzed only European-ancestry/Caucasian samples, and the authors explicitly say non-European populations were not examined and should be a focus for future work.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1371/journal.pgen.1000696

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Association of 544 MHC region SNPs (out of 1,974) and HLA-DRB1 with SLE. Shown are results for variants with p<0.01 among 1,484 SLE cases and 650 controls. UNPHASED v.3.0.10 was used for 1,974 SNPs and SAS v. 9.1.3 for HLA-DRB1 global p-value. Odds ratio shown for HLA-DRB1 corresponds to *0301 allele.
Figure 1 Association of 544 MHC region SNPs (out of 1,974) and HLA-DRB1 with SLE. Shown are results for variants with p<0.01 among 1,484 SLE cases and 650 controls. UNPHASED v.3.0.10 was used for 1,974 SNPs and SAS v. 9.1.3 for HLA-DRB1 global p-value. Odds ratio shown for HLA-DRB1 corresponds to *0301 allele.CC BY · PubMed Central
Figure 2 Summary of analytical plan. Summary of analytical plan for defining MHC region genetic variants with independent contributions to SLE risk among 1,484 SLE cases and 650 controls.
Figure 2 Summary of analytical plan. Summary of analytical plan for defining MHC region genetic variants with independent contributions to SLE risk among 1,484 SLE cases and 650 controls.CC BY · PubMed Central
Figure 3 Summary of MHC region variants with evidence of independent association with SLE. Summary of MHC region variants (n = 11, including HLA-DRB1) with evidence of independent association with SLE (p<0.001) based on conditional haplotype and stepwise logistic regression analyses. Number in parentheses indicates number of SNPs at that locus. See Figure 2 for details of overall analytical strategy. P-values from original univariate analyses are shown on the y-axis.
Figure 3 Summary of MHC region variants with evidence of independent association with SLE. Summary of MHC region variants (n = 11, including HLA-DRB1) with evidence of independent association with SLE (p<0.001) based on conditional haplotype and stepwise logistic regression analyses. Number in parentheses indicates number of SNPs at that locus. See Figure 2 for details of overall analytical strategy. P-values from original univariate analyses are shown on the y-axis.CC BY · PubMed Central
Figure 4 Linkage disequilibrium (LD) plot for HLA-DRB1 and 10 MHC region SNPs. LD plot showing correlation (r2) for HLA-DRB1 and 10 MHC region SNPs demonstrating evidence of independent association with SLE. A total of 2,607 individuals with >90% European ancestry (maximum unrelated subset of all cases and trios) were used for analysis. Similar results were obtained when only the SLE cases or SLE trio family founders were used to generate the LD plots (data not shown). HLA-DRB1 was coded as a biallelic marker (DRB1*0301 vs. others) for analysis in Haploview based on results obtained for LD analyses of this locus as a multilocus marker using UNPHASED (see Methods). See Table 3 for other gene names.
Figure 4 Linkage disequilibrium (LD) plot for HLA-DRB1 and 10 MHC region SNPs. LD plot showing correlation (r2) for HLA-DRB1 and 10 MHC region SNPs demonstrating evidence of independent association with SLE. A total of 2,607 individuals with >90% European ancestry (maximum unrelated subset of all cases and trios) were used for analysis. Similar results were obtained when only the SLE cases or SLE trio family founders were used to generate the LD plots (data not shown). HLA-DRB1 was coded as a biallelic marker (DRB1*0301 vs. others) for analysis in Haploview based on results obtained for LD analyses of this locus as a multilocus marker using UNPHASED (see Methods). See Table 3 for other gene names.CC BY · PubMed Central

Verification

Claims the paper makes

1 Valid · 0 Not valid · 1 Not checked · 52 Own results and interpretations

26 more claims

Create a free account to see all 54 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 16
  • Probably not a substantial claim. 13

Create a free account to see these claims.

Citations

Cites

Show all 50 references

Cited by

See all 131

Metadata

Authors
Barcellos, L. F., May, S. L., Ramsay, P. P., Quach, H. L., Lane, J. A., Nititham, J., Noble, J. A., Taylor, K. E., Quach, D. L., Chung, S. A., Kelly, J. A., Moser, K. L., Behrens, T. W., Seldin, M. F., Thomson, G., Harley, J. B., Gaffney, P. M., & Criswell, L. A.
Affiliations
  • University of California, Berkeley (US)
  • UCSF Benioff Children's Hospital (US)
  • University of California, San Francisco (US)
  • Oklahoma Medical Research Foundation (US)
  • Genentech (US)
  • University of California, Davis (US)
Corresponding author
Criswell, Lindsey A.
Venue
PLoS Genetics
Published
2009-10-23
Volume
5
Issue
10
Pages
e1000696
ISSN
  • 1553-7390 (ISSN-L)
  • 1553-7404
OpenAlex
W2010016129
Cited by
131
References
50
Citations by year
2026: 3 · 2025: 2 · 2024: 8 · 2023: 1 · 2022: 5 · 2021: 2 · 2020: 4 · 2019: 4 · 2018: 8 · 2017: 9 · 2016: 8 · 2015: 8 · 2014: 11 · 2013: 13 · 2012: 19
FWCI
10.61
Type
journal article
Language
en
Open access
Locations
  • PLoS Genetics (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • eScholarship (California Digital Library) (submittedVersion)
  • eScholarship (California Digital Library) (submittedVersion, cc-by)
  • Figshare (submittedVersion, cc-by)
Funders
  • U.S. Department of Veterans Affairs
  • Lupus Research Alliance
  • National Institutes of Health (n01ar62277-9-0-1, n01ai40076-11-0-2, 5m01rr000079-42, AI063274, AI24717, AI40076, AI62629)
  • University of California, San Francisco
  • National Institute of Allergy and Infectious Diseases (AI62629, AI-31584, AI-24717, R01AI063274, R37AI024717, R01AI031584, AI53747, AI-063274, R21AI053747, R56AI063274, U19AI062629, N01 AI040076, R01AI024717)
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR052125, AR19084, R01AR042460, R01AR043274, AR-052300, AR043274, AR02175, R01AR052300, P30AR053483, AR 42460, N01-AR062277, AR22804, AR052125, K24AR002175, P50AR048940, AR 48940)
  • National Institute of Dental and Craniofacial Research (DE15223, R01DE015223)
  • National Center for Research Resources (RR20143, P20RR020143, M01-RR000079)
Topics
  • Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
  • Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
Keywords
systemic lupus erythematosus, major histocompatibility complex, HLA-DRB1, HLA-DRB1*0301, HLA-DRB1*1501, MICB, ancestry informative markers, haplotype association, risk genes
MeSH terms
Adult, Female, HLA-DR Antigens, Humans, Lupus Erythematosus, Systemic, Major Histocompatibility Complex, Male, Middle Aged, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, White People, Young Adult, HLA-DRB1 Chains

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: High-Density SNP Screening of the Major Histocompatibility Complex in Systemic Lupus Erythematosus Demonstrates Strong Evidence for Independent Susceptibility Regions. https://app.cochat.ai/papers/10.1371/journal.pgen.1000696
The paper
Barcellos, L. F., May, S. L., Ramsay, P. P., Quach, H. L., Lane, J. A., Nititham, J., Noble, J. A., Taylor, K. E., Quach, D. L., Chung, S. A., Kelly, J. A., Moser, K. L., Behrens, T. W., Seldin, M. F., Thomson, G., Harley, J. B., Gaffney, P. M., & Criswell, L. A. (2009). High-Density SNP Screening of the Major Histocompatibility Complex in Systemic Lupus Erythematosus Demonstrates Strong Evidence for Independent Susceptibility Regions. PLoS Genetics. https://doi.org/10.1371/journal.pgen.1000696

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.